$NATR
NATURES SUNSHINE PRODUCTS INC Stock $natr

$natr Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024021178 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$110.6M	$111.0M
YoY Change	-5.15%	2.17%
Cost Of Revenue	$31.66M	$32.02M
YoY Change	-0.81%	1.02%
Gross Profit	$78.89M	$78.98M
YoY Change	-6.78%	2.65%
Gross Profit Margin	71.36%	71.16%
Selling, General & Admin	$38.56M	$40.78M
YoY Change	-8.79%	-6.55%
% of Gross Profit	48.88%	51.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.499M	$3.160M
YoY Change	23.51%	12.66%
% of Gross Profit	4.44%	4.0%
Operating Expenses	$38.56M	$40.78M
YoY Change	-8.79%	-6.55%
Operating Profit	$5.637M	$4.624M
YoY Change	-19.89%	2588.37%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$1.214M	$31.00K
YoY Change	11.68%	-97.95%
Pretax Income	$4.423M	$4.655M
YoY Change	-25.66%	176.1%
Income Tax	$2.935M	$2.165M
% Of Pretax Income	66.36%	46.51%
Net Earnings	$1.349M	$2.321M
YoY Change	-44.3%	169.88%
Net Earnings / Revenue	1.22%	2.09%
Basic Earnings Per Share	$0.07	$0.12
Diluted Earnings Per Share	$0.07	$0.12
COMMON SHARES
Basic Shares Outstanding	18.73M shares	18.82M shares
Diluted Shares Outstanding	19.12M shares	19.22M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$68.70M	$77.77M
YoY Change	-0.4%	18.34%
Cash & Equivalents	$68.70M	$77.77M
Short-Term Investments
Other Short-Term Assets	$9.747M	$10.04M
YoY Change	13.22%	-6.22%
Inventory	$62.30M	$62.65M
Prepaid Expenses
Receivables	$11.29M	$9.694M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$152.0M	$160.2M
YoY Change	-2.48%	3.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$44.83M	$45.27M
YoY Change	-1.19%	-1.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$890.0K	$802.0K
YoY Change	20.27%	11.7%
Other Assets	$9.647M	$9.794M
YoY Change	-3.58%	-4.44%
Total Long-Term Assets	$83.80M	$87.11M
YoY Change	4.42%	8.67%
TOTAL ASSETS
Total Short-Term Assets	$152.0M	$160.2M
Total Long-Term Assets	$83.80M	$87.11M
Total Assets	$235.8M	$247.3M
YoY Change	-0.14%	5.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.422M	$9.029M
YoY Change	21.39%	2.89%
Accrued Expenses	$22.99M	$23.26M
YoY Change	-21.07%	-19.05%
Deferred Revenue	$2.217M	$1.877M
YoY Change	55.03%	66.4%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$63.65M	$68.88M
YoY Change	-10.37%	-3.77%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$2.107M
YoY Change
Other Long-Term Liabilities	$1.403M	$983.0K
YoY Change	34.77%	-5.48%
Total Long-Term Liabilities	$1.403M	$983.0K
YoY Change	34.77%	-5.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$63.65M	$68.88M
Total Long-Term Liabilities	$1.403M	$983.0K
Total Liabilities	$79.43M	$87.56M
YoY Change	-8.44%	-0.35%
SHAREHOLDERS EQUITY
Retained Earnings	$53.38M	$52.03M
YoY Change	40.78%	46.59%
Common Stock	$114.0M	$119.1M
YoY Change	-7.23%	-2.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$150.6M	$154.1M
YoY Change
Total Liabilities & Shareholders Equity	$235.8M	$247.3M
YoY Change	-0.14%	5.41%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$1.349M	$2.321M
YoY Change	-44.3%	169.88%
Depreciation, Depletion And Amortization	$3.499M	$3.160M
YoY Change	23.51%	12.66%
Cash From Operating Activities	$1.305M	$2.190M
YoY Change	-83.56%	-76.51%
INVESTING ACTIVITIES
Capital Expenditures	$3.351M	$3.689M
YoY Change	38.36%	58.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$3.351M	-$3.689M
YoY Change	38.36%	58.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-8.418M	$107.0K
YoY Change	1181.28%	-109.26%
NET CHANGE
Cash From Operating Activities	1.305M	$2.190M
Cash From Investing Activities	-3.351M	-$3.689M
Cash From Financing Activities	-8.418M	$107.0K
Net Change In Cash	-10.46M	-$4.600M
YoY Change	-315.31%	-180.87%
FREE CASH FLOW
Cash From Operating Activities	$1.305M	$2.190M
Capital Expenditures	$3.351M	$3.689M
Free Cash Flow	-$2.046M	-$1.499M
YoY Change	-137.09%	-121.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	802000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	747000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1515000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	983000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	644000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	87560000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	90233000	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18786000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18786000	shares
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	2107000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	0	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1401000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	2490000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1253000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1692000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1653000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	798000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-400000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	159540000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1369000	usd
CY2024Q1	natr	Stock Issued During Period Value Stock Options And Restricted Stock Exercised StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised	-152000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1848000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	2490000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1692000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	159707000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	147047000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1058000	usd
CY2023Q1	natr	Stock Issued During Period Value Stock Options And Restricted Stock Exercised StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised	-165000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	823000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1253000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1653000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	146717000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	2490000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1253000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3160000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2805000	usd
CY2024Q1	natr	Operating Lease Non Cash Lease Expense OperatingLeaseNonCashLeaseExpense	1197000	usd
CY2023Q1	natr	Operating Lease Non Cash Lease Expense OperatingLeaseNonCashLeaseExpense	932000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1369000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1058000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-71000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-157000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-631000	usd
CY2024Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	14000	usd
CY2023Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	0	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	21000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Securities Operating Activities ProceedsFromSaleOfSecuritiesOperatingActivities	31000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	62000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	47000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-20000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	1477000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1136000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3649000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3389000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-457000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2415000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3266000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	409000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	11000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1099000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2391000	usd
CY2024Q1	natr	Increase Decreasein Accrued Volume Incentivesand Service Fees IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees	-101000	usd
CY2023Q1	natr	Increase Decreasein Accrued Volume Incentivesand Service Fees IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees	781000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6802000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2759000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	108000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1142000	usd
CY2024Q1	natr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1002000	usd
CY2023Q1	natr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-900000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	965000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	586000	usd
CY2024Q1	natr	Increase Decrease In Liability Related To Unrecognized Tax Positions IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions	415000	usd
CY2023Q1	natr	Increase Decrease In Liability Related To Unrecognized Tax Positions IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions	6000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	55000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	16000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2190000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9325000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3689000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2325000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3689000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2325000	usd
CY2024Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	318000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	4808000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	433000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	2701000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	283000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	152000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	165000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1848000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	823000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	107000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1156000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3208000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-156000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4600000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5688000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82373000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60032000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77773000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65720000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1383000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1991000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	12000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	25000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.</span></div>The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions.
CY2024Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	200000	usd
CY2023Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	400000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	5700000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	5500000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	17650000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	18301000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1594000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1218000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	43409000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	47376000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	62653000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	66895000	usd
CY2024Q1	us-gaap	Debt Securities Trading Restricted DebtSecuritiesTradingRestricted	800000	usd
CY2023Q4	us-gaap	Debt Securities Trading Restricted DebtSecuritiesTradingRestricted	700000	usd
CY2024Q1	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	62000	usd
CY2023Q1	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	47000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2321000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	860000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18828000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19061000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18828000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19061000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	396000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	372000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19224000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19433000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024Q1	natr	Dilutive Securities Excludedfrom Computationof Earnings DilutiveSecuritiesExcludedfromComputationofEarnings	801000	shares
CY2023Q1	natr	Dilutive Securities Excludedfrom Computationof Earnings DilutiveSecuritiesExcludedfromComputationofEarnings	520000	shares
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	102000	shares
CY2021Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	30000000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	105000	shares
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	90000	shares
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1800000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	800000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	15800000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110993000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	108634000	usd
CY2024Q1	natr	Contribution Margin ContributionMargin	45408000	usd
CY2023Q1	natr	Contribution Margin ContributionMargin	43814000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	40784000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	43642000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	4624000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	172000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	31000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1514000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4655000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1686000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110993000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	108634000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110993000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	108634000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45271000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45000000	usd
CY2024Q1	us-gaap	Assets Assets	247267000	usd
CY2023Q4	us-gaap	Assets Assets	249773000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.465
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.257
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	600000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	300000	usd
CY2024Q1	natr	Revenuefrom Contractwith Customer Refund Period RevenuefromContractwithCustomerRefundPeriod	P90D
CY2024Q1	natr	Numberof Principal Categoriesof Products NumberofPrincipalCategoriesofProducts	6	product_category
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-021178-index-headers.html	Edgar Link	pending
0001628280-24-021178-index.html	Edgar Link	pending
0001628280-24-021178.txt	Edgar Link	pending
0001628280-24-021178-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
natr-20240331.htm	Edgar Link	pending
natr-20240331.xsd	Edgar Link	pending
natr-20240331_g1.jpg	Edgar Link	pending
natr2024331-ex311.htm	Edgar Link	pending
natr2024331-ex312.htm	Edgar Link	pending
natr2024331-ex313.htm	Edgar Link	pending
natr2024331-ex321.htm	Edgar Link	pending
natr2024331-ex322.htm	Edgar Link	pending
natr2024331-ex323.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
natr-20240331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
natr-20240331_lab.xml	Edgar Link	unprocessable
natr-20240331_pre.xml	Edgar Link	unprocessable
natr-20240331_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
natr-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NATR
NATURES SUNSHINE PRODUCTS INC Stock $natr

2024 Q2 Form 10-Q Financial Statement

#000162828024021178 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NATR NATURES SUNSHINE PRODUCTS INC Stock $natr

2024 Q2 Form 10-Q Financial Statement

#000162828024021178 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NATR
NATURES SUNSHINE PRODUCTS INC Stock $natr